Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Comparison of Fluorescence in Situ Hybridization and Flow Cytometry (Flow-FISH) with Monochrome Multiplex Quantitative Polymerase Chain Reaction (MM-qPCR) for Telomere Length Screening in Adult Patients with Suspected Cryptic Dyskeratosis Congenita (DKC)

Monica Sofia Ventura Ferreira, PhD, Natalia Estrada, Martin Kirschner, MD, Blanca Xicoy, Anne-Sophie Bouillon, MD, Stefan Wilop, MD, Steffen Koschmieder, MD, Jens P. Panse, MD, Tim H. Brümmendorf, MD, Fabian Beier, MD

Blood (2018) 132 (Supplement 1): 3861.

https://doi.org/10.1182/blood-2018-99-117330

Published: 2018

Journal Articles

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Martin Kirschner, MD, Monica Sofia Ventura Ferreira, PhD, Anne-Sophie Bouillon, MD, Marcin W. Wlodarski, MD PhD, Michaela Schwarz, MD, Stefan Balabanov, MD PhD, Stefan Wilop, MD, Steffen Koschmieder, MD, Jens P. Panse, MD, Tim H. Brümmendorf, MD, Fabian Beier, MD

Blood (2018) 132 (Supplement 1): 2585.

https://doi.org/10.1182/blood-2018-99-118197

Published: 2018

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Andreas Hüttmann, MD, Stefan P Müller, MD, Jan Rekowski, Dipl.-Stat., Bernd Hertenstein, MD, Christiane Franzius, MD, Anke Franzke, MD, Frank M Bengel, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Paul La Rosée, MD, Martin Freesmeyer, MD, Heinz-Gert Hoeffkes, MD, Andreas Hertel, MD, Dirk Behringer, Rolf Mesters, MD, Matthias Weckesser, MD, Stefan Mahlmann, MD, Uwe Haberkorn, MD, Uwe Martens, MD, Gabriele Prange-Krex, MD, Agnieszka Korfel, MD, Winfried Brenner, MD, Aristoteles Giagounidis, Regina Moeller, MD, Volker Runde, MD, Matthias Sandmann, MD, Hubertus Hautzel, MD, Stefan Wilop, MD, Thomas Krohn, MD, Heinz Dürk, MD, Dirk Strumberg, MD, Michael Heike, MD, Claudia Ose, Marcus Brinkmann, Guido Trenn, MD, Otto Kloke, MD, Christiane Kreisel-Büstgens, MD, Tu-Anh Dang, MD, Gerhard Heil, Karl-Heinz Jöckel, PhD, Dieter Hoelzer, MD, Wolfram Klapper, MD, Ulrich Duehrsen, MD

Blood (2016) 128 (22): 185.

https://doi.org/10.1182/blood.V128.22.185.185

Published: 2016

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Ulrich Duehrsen, MD, Stefan P Müller, MD, Jan Rekowski, Dipl.-Stat., Bernd Hertenstein, MD, Christiane Franzius, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Anke Franzke, MD, Frank M Bengel, MD, Paul La Rosée, MD, Martin Freesmeyer, MD, Heinz-Gert Hoeffkes, MD, Andreas Hertel, MD, Dirk Behringer, Gabriele Prange-Krex, MD, Martin Griesshammer, MD, Jens Holzinger, MD, Stefan Wilop, MD, Thomas Krohn, MD, Aruna Raghavachar, MD, Georg Maschmeyer, MD, Ingo Brink, MD, Roland Schroers, MD, Tobias Gaska, MD, Tu-Anh Dang, MD, Aristoteles Giagounidis, Ariane Dienst, MD, Hubertus Hautzel, MD, Ralph Naumann, MD, Alfred Klein, MD, Dennis Hahn, MD, Gabriele Pöpperl, MD, Matthias Grube, MD, Jörg Marienhagen, MD, Andreas Schwarzer, MD, Lars Kurch, MD, Thomas Höhler, MD, Heike Steiniger, MD, Holger Nückel, MD, Thomas Südhoff, MD, Wolfgang Römer, MD, Marcus Brinkmann, Claudia Ose, Dieter Hoelzer, MD, Jan Dürig, MD, Karl-Heinz Jöckel, PhD, Wolfram Klapper, MD, Andreas Hüttmann, MD

Blood (2016) 128 (22): 1857.

https://doi.org/10.1182/blood.V128.22.1857.1857

Published: 2016

Journal Articles

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Patricia Johansson, MD, Jan Dürig, MD, Jan Rekowski, Dipl.-Stat., Stefan P Müller, MD, Bernd Hertenstein, MD, Christiane Franzius, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Paul La Rosée, Prof. Dr. MD, Martin Freesmeyer, MD, Stefan Wilop, MD, Thomas Krohn, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD

Blood (2015) 126 (23): 3880.

https://doi.org/10.1182/blood.V126.23.3880.3880

Published: 2015

Journal Articles

The 3-OH Derivative of the Polychlorinated Biphenyl (PCB)-28 Inhibits Telomerase Expression and Accelerates Telomere Shortening in Vitro : A Rationale for the Significantly Shortened Telomere Length Found in Peripheral Blood Lymphocytes of Workers Exposed to High Doses of Lower Chlorinated PCBs

Patrick Ziegler, PhD, Thomas Schettgen, PhD, Stefan Wilop, MD, Natalia Soares Quintete, PhD, Susanne Ziegler, PhD, Fabian Beier, MD, Monica S.V. Ferreira, PhD, Peter Uciechowski, PhD, Lothar Rink, PhD, Thomas Kraus, MD, Tim H. Brümmendorf, MD

Blood (2014) 124 (21): 4139.

https://doi.org/10.1182/blood.V124.21.4139.4139

Published: 2014

Journal Articles

Evidence for Premature Aging of (Clonal but also) Non-Clonal Hematopoietic Stem Cells in Patients with Acute Myeloid Leukemia (AML)

Martina Crysandt, MD, Monica S.V. Ferreira, PhD, Patrick Ziegler, PhD, Sebastian Hummel, Julian Kaufmann, Stefan Wilop, MD, Edgar Jost, MD, Wolfgang Wagner, MD PhD, Tim H. Brummendorf, MD PhD, Fabian Beier, MD

Blood (2014) 124 (21): 1048.

https://doi.org/10.1182/blood.V124.21.1048.1048

Published: 2014

Journal Articles

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Blood (2014) 124 (21): 391.

https://doi.org/10.1182/blood.V124.21.391.391

Published: 2014

Journal Articles

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Fabian Beier, MD, Ulrich Germing, MD, Guntram Büsche, MD, Patrick Ziegler, PhD, Stefan Wilop, MD, Lucia Vankann, Norbert Gattermann, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, PhD, Katharina S. Götze, MD, Wolf-Karsten Hofmann, Detlef Haase, MD, PhD, Hans Kreipe, MD, Jens Panse, MD, Tim H. Brümmendorf, MD

Blood (2013) 122 (21): 2781.

https://doi.org/10.1182/blood.V122.21.2781.2781

Published: 2013

Journal Articles

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Katrin Wenn, Lena Tomala, Fabian Beier, MD, Stefan Wilop, MD, Lucia Vankann, Christian Hasenbank, Oliver Frank, Claudia Walasek, Andreas Hochhaus, MD, Frank Giles, MD MB, Steffen Koschmieder, Patrick Ziegler, PhD, Tim H. Brümmendorf, MD

Blood (2013) 122 (21): 1471.

https://doi.org/10.1182/blood.V122.21.1471.1471

Published: 2013

Journal Articles

Sustained Alterations In Bone Marrow Stromal Cells From Patients With Myeloproliferative Neoplasms (MPN) Contribute To Remodelling Of The Bone Marrow Microenvironment Prior To The Manifestation Of Myelofibrosis

Rebekka K. Schneider, MD, Isabelle Leisten, Susanne Ziegler, PhD, Anne Schumacher, Björn Rath, MD, Dirk Fahrenkamp, Gerhard Mueller-Newen, PhD, Martina Crysandt, MD, Stefan Wilop, MD, Edgar Jost, MD, Ruth Knuechel, MD, Tim H. Bruemmendorf, MD, Patrick Ziegler, PhD

Blood (2013) 122 (21): 4102.

https://doi.org/10.1182/blood.V122.21.4102.4102

Published: 2013

Journal Articles

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

Martina Crysandt, MD, Edgar Jost, MD, Susanne Isfort, MD, Tim H Brümmendorf, Stefan Wilop, MD

Blood (2012) 120 (21): 1522.

https://doi.org/10.1182/blood.V120.21.1522.1522

Published: 2012

Journal Articles

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Markus Ertmer, Djordje Atanackovic, Lucia Vankann, Stefan Wilop, MD, Eray Gökkurt, MD, Tim H Brümmendorf, Jens Panse, MD

Blood (2012) 120 (21): 4969.

https://doi.org/10.1182/blood.V120.21.4969.4969

Published: 2012

Journal Articles

Telomere Elongation In Vivo and Clinical Response Upon Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation,

Tim H Brümmendorf, Patrick Ziegler, PhD, Jamil Akkad, MD, Ute Brassat, PhD, Lucia Vankann, Jens Panse, MD, Stefan Wilop, MD, Stefan Balabanov, MD, PhD, Klaus Schwarz, MD, Uwe M. Martens, MD, PhD, Hubert Schrezenmeier, MD

Blood (2011) 118 (21): 3427.

https://doi.org/10.1182/blood.V118.21.3427.3427

Published: 2011

Journal Articles

Therapy of Acquired Aplastic Anemia (AA) with Rabbit Antithymocyte Globulin (rATG): A Retrospective Analysis by the Working Group on Non-Malignant Disorders of Hematopoiesis of the German Society of Hematology and Oncology (DGHO),

Blood (2011) 118 (21): 3434.

https://doi.org/10.1182/blood.V118.21.3434.3434

Published: 2011

Journal Articles

Epigenetic Dysregulation of the Tissue Inhibitor of Metalloproteinases-2 Gene in Multiple Myeloma

Oliver Galm, Edgar Jost, MD, Claudia Schubert, James G. Herman, MD, Tim H Brümmendorf, Stefan Wilop, MD

Blood (2011) 118 (21): 5089.

https://doi.org/10.1182/blood.V118.21.5089.5089

Published: 2011

Journal Articles

Hypercholesterolemia and Its Association with Enhanced Stem Cell Mobilization and Harvest After High-Dose Cyclophosphamide + G-CSF

Martina Crysandt, Ralf-Dieter Hilgers, Sabine von Hobe, Albrecht Eisert, Edgar Jost, Jens Panse, Tim H. Brummendorf, Stefan Wilop

Blood (2010) 116 (21): 2247.

https://doi.org/10.1182/blood.V116.21.2247.2247

Published: 2010

Journal Articles

Epigenetic Downregulation of Secreted Frizzled-Related Proteins In Philadelphia Positive and Philadelphia Negative Myeloproliferative Neoplasms

Karla Bennemann, MD, Claudia Schubert, Stefan Wilop, MD, Tim H. Brummendorf, MD, Oliver Galm, MD, Edgar Jost, MD

Blood (2010) 116 (21): 4647.

https://doi.org/10.1182/blood.V116.21.4647.4647

Published: 2010

Journal Articles

Friday leukemia: myth or reality?

Stefan Wilop, Oliver Galm, Laura Thompson, Rainhardt Osieka, Tim H. Brummendorf, Edgar Jost

Blood (2010) 115 (4): 912.

https://doi.org/10.1182/blood-2009-11-255240

Published: 2010

Journal Articles

Epigenetic Inactivation of the Secreted Frizzled-Related Protein Gene Family in Multiple Myeloma.

Edgar Jost, MD, Deniz Gezer, Stefan Wilop, MD, James G. Herman, MD, Rainhardt Osieka, MD, Oliver Galm, MD

Blood (2007) 110 (11): 2131.

https://doi.org/10.1182/blood.V110.11.2131.2131

Published: 2007

NARROW

Comparison of Fluorescence in Situ Hybridization and Flow Cytometry (Flow-FISH) with Monochrome Multiplex Quantitative Polymerase Chain Reaction (MM-qPCR) for Telomere Length Screening in Adult Patients with Suspected Cryptic Dyskeratosis Congenita (DKC)

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

The 3-OH Derivative of the Polychlorinated Biphenyl (PCB)-28 Inhibits Telomerase Expression and Accelerates Telomere Shortening in Vitro : A Rationale for the Significantly Shortened Telomere Length Found in Peripheral Blood Lymphocytes of Workers Exposed to High Doses of Lower Chlorinated PCBs

Evidence for Premature Aging of (Clonal but also) Non-Clonal Hematopoietic Stem Cells in Patients with Acute Myeloid Leukemia (AML)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Sustained Alterations In Bone Marrow Stromal Cells From Patients With Myeloproliferative Neoplasms (MPN) Contribute To Remodelling Of The Bone Marrow Microenvironment Prior To The Manifestation Of Myelofibrosis

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Telomere Elongation In Vivo and Clinical Response Upon Androgen Treatment in a Patient with Aplastic Anemia and a Heterozygous hTERT Gene Mutation,

Therapy of Acquired Aplastic Anemia (AA) with Rabbit Antithymocyte Globulin (rATG): A Retrospective Analysis by the Working Group on Non-Malignant Disorders of Hematopoiesis of the German Society of Hematology and Oncology (DGHO),

Epigenetic Dysregulation of the Tissue Inhibitor of Metalloproteinases-2 Gene in Multiple Myeloma

Hypercholesterolemia and Its Association with Enhanced Stem Cell Mobilization and Harvest After High-Dose Cyclophosphamide + G-CSF

Epigenetic Downregulation of Secreted Frizzled-Related Proteins In Philadelphia Positive and Philadelphia Negative Myeloproliferative Neoplasms

Friday leukemia: myth or reality?

Epigenetic Inactivation of the Secreted Frizzled-Related Protein Gene Family in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only